Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.
Where this comes from
- Record sourced from PubMed, PMID 33524280.
- Also identified by DOI 10.7326/ACPJ202102160-016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stone JH, Frigault MJ, Serling-Boyd NJ, et al. <b>Efficacy of tocilizumab in patients hospitalized with Covid-19.</b> N Engl J Med. 2020;383:2333-44. 33085857.
Medical subject headings
- Antibodies, Monoclonal, Humanized
- Respiratory Insufficiency
- COVID-19 Drug Treatment